News Releases
This section of the website contains information that should be considered accurate as of the date presented. You acknowledge that this information may change over time and you should not assume that the information is accurate at a later date. Quest Diagnostics is not obligated to update the information contained in this section of the website.
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
05 08 2018 Prescription opiate positivity rate drops by double digits, while cocaine rises by double digits in certain statesDriven by increases in cocaine, methamphetamine and marijuana, drug use by the American workforce remains at its highest rate in more than a decade, according to a new analysis released today by...
-
05 07 2018 Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that it was selected by Forbes as one of America's Best Large Employers...
-
05 04 2018 Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at the Deutsche Bank 43rd Annual Health Care...
-
04 19 2018 - Revenues of $1.88 billion, up 3.7% from 2017Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced today financial results for the first quarter ended March 31, 2018. "We...
04 09 2018 One in four clinicians surveyed will disregard screening guidelines for chlamydia and/or gonorrhea if a patient is asymptomaticDespite record high rates of new cases of sexually transmitted diseases (STDs), young women who are sexually active often don't talk to their clinicians about sex and STD risk, and many aren't...
-
04 06 2018 Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it will report first quarter 2018 results on Thursday, April 19, 2018,...
-
04 02 2018 LOUISVILLE, Ky. & NEW YORK & SECAUCUS, N.J. & MINNETONKA, Minn.--April 2, 2018--Five leading health care organizations – Humana (NYSE: HUM), MultiPlan, Quest Diagnostics (NYSE: DGX) and...
02 26 2018 Collaboration will leverage insights from Quest’s Blueprint for Athletes biometric testing service data to examine physiological changes, performance variables in competitive athletes at the newly created Quest Diagnostics Sports Science Laboratory at the Rutgers–New Brunswick Center for Health & Human PerformanceSecaucus, NJ and New Brunswick, NJ, Feb. 26, 2018 (GLOBE NEWSWIRE) -- Quest Diagnostics (NYSE: DGX), the world’s leading provider of diagnostic information services, and Rutgers University–New...
-
02 22 2018 Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at the Raymond James 39th Annual Institutional...
-
02 01 2018 Transaction expands Quest’s scale and reach in the mobile provider segment and bolsters its extended care capabilitiesSECAUCUS, N.J. — February 1, 2018 — Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced it has completed its previously announced...
-
02 01 2018 - Fourth quarter revenues of $1.94 billion, up 4.1% versus 2016Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced today financial results for the fourth quarter and full year ended December...
01 30 2018 Tenth time ChartMaxx honored with top industry ranking*Secaucus, NJ, Jan. 30, 2018 (GLOBE NEWSWIRE) -- Quest Diagnostics (NYSE: DGX), the world’s leading provider of diagnostic information services, announced today that its ChartMaxx® enterprise...
-
01 23 2018 Acquisition to strengthen Quest's mobile provider capabilities and population health management solutions for health plansQuest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced it has formed a definitive agreement to acquire Mobile Medical Examination Service...
-
01 19 2018 Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that it has been named one of the "World's Most Admired Companies" for 2018 by...
-
01 19 2018 Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it will report fourth quarter and full year 2017 results on Thursday,...
-
01 03 2018 Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at the 36th Annual J.P. Morgan Healthcare...
-
12 12 2017 Transaction broadens access to Quest's diagnostic innovations in the New York-New Jersey metropolitan areaQuest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced it has completed its previously announced acquisition of the Shiel Medical...
-
12 11 2017 Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, announced its support for a lawsuit filed by the American Clinical Laboratory Association (ACLA)...
-
12 01 2017 Cleveland HeartLab's Laboratory Facility is Now Quest's National Cardiometabolic Center of Excellence, Serving Physicians and Patients Seeking to Identify and Address Hidden Risks of Heart DiseaseQuest Diagnostics (NYSE: DGX) today announced that it has completed its previously announced acquisition of Cleveland HeartLab. Quest will establish a national center of excellence focused on...
-
11 29 2017 Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that its Board of Directors declared a quarterly cash dividend of $0.45 per share,...
-
11 20 2017 Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today provided an update on the impact of the Centers for Medicare and Medicaid Services (CMS)...
-
11 13 2017 At-home collection, one-day fecal immunochemical test that meets American Cancer Society guidelines and HEDIS quality measures for lower gastrointestinal bleeding screening programsBridgewater, N.J., and Secaucus, N.J., Nov. 13, 2017 -- Clinical Genomics, a private company and Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services,...
-
11 01 2017 Five Presentations Show the Clinical Value of Diagnostic Innovations for Assessing Prevalent Autoimmune Diseases, Including Rheumatoid Arthritis and LupusSecaucus, NJ, Nov. 01, 2017 (GLOBE NEWSWIRE) -- Quest Diagnostics (NYSE: DGX), the world’s leading provider of diagnostic information services, announced today that it will present results of...
-
10 30 2017 Transaction Expands Access to Innovative, High-Value Diagnostic Information Services in Southern CaliforniaQuest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced it has acquired certain assets of California Laboratory Associates (CLA), a clinical...
-
10 19 2017 - Third quarter revenues of $1.93 billion, up 2.4% versus 2016.Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced today financial results for the third quarter ended September 30, 2017. "We...